| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3899725 | Urology | 2012 | 6 Pages |
Abstract
ATORV administration significantly prevented and restored impairment in GFR and renal vascular resistance. Furthermore, ATORV also improved urinary concentration by reversing the BUO-induced downregulation of AQP2. These findings have significant clinical implication in treating obstructive nephropathy.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Alexandre Danilovic, Roberto Iglesias Lopes, Talita Rojas Sanches, Maria HeloÃsa Massola Shimizu, FabÃola M. Oshiro, Lúcia Andrade, Francisco Tibor Dénes, Antonio Carlos Seguro,